Angelike Kefalas, Mba Email and Phone Number
Chief Business Officer | Chief Commercial Officer | Advisor | Business Strategy & Scaling | Revenue Growth | Board Member at
@
Muse® by Interaxon Inc.
Angelike Kefalas, Mba's Location
San Francisco Bay Area, United States, United States
Angelike Kefalas, Mba's Contact Details
Angelike Kefalas, Mba work email
- Valid
- Valid
- Valid
Angelike Kefalas, Mba personal email
- Valid
Angelike Kefalas, Mba phone numbers
About Angelike Kefalas, Mba
Entrepreneurial-minded VP/C-level Commercial, Business and Sales Growth Leader with >20 years of experience at A.I. tech-enabled digital health, diagnostic, medical device and biotechnology companies. I've been a key member of several leadership teams and am skilled at establishing revenue as well as sourcing and negotiating partner & channel deals, managing P&Ls with $100M - $1B in ARR, and launching FDA products. In addition, I'm a seasoned start-up Executive who is experienced at fundraising, building companies, creating go-to-market plans and M&A exits. Proven track record of exceeding sales targets and building high-performing teams. I'm passionate about bringing great technology and products to market to improve patient lives. THERAPEUTIC AREA EXPERIENCE Infectious Disease, Cancer, Women’s Reproductive Health, Cardiovascular, Neuropathic Pain, Diabetes, Obesity, and Metabolic SyndromeAREAS OF EXPERTISE Raising Capital (Fundraising with VC & PE) • Proven Sales Management Skills, with a track record of driving sales growth and achieving sales targets • Managerial Leadership and Staff Mentoring • 15+ yrs Cross-functional Team Leadership with experience running global teams with multiple levels of management • Evaluating and Presenting new licensing, partnership and M&A opportunities • Investing & Corporate Development • Go-To-Market (GTM) Strategy & Execution • M&A ExitSALES EXPERTISEDTC, B2C and B2B Enterprise account-based sales + Biotech & Pharmaceutical in-licensing + selling to Health Insurance companies • Sales Leadership & Training • Creating Sales Playbooks, Selling to: Hospitals, Clinics, Telehealth Partners, Physician Specialists, HCPs, Patients, Consumers, Payers, Pharma, Government agencies • Creating Innovative Selling Strategies & Sales Campaigns • Pricing, Coding (HCPCS, ICD, DRG, and CPT codes) & Reimbursement • 10+ yrs leading and running the Medical, Legal, and Regulatory committee for regulatory complianceANALYTICAL SKILLSFinancial Modeling (aptitude for building valuation models, cash-flow models, NPVs, ROIs, P&L forecasts and department budgets) • Qualitative and Quantitative Market ResearchMARKETING SKILLS Proficient in digital marketing techniques and platforms, including Salesforce, social media, email marketing, and analytics. • I’m also adept at developing and executing strategies to enhance brand awareness, promote programs, and drive revenue.
Angelike Kefalas, Mba's Current Company Details
Muse® By Interaxon Inc.
View
Chief Business Officer | Chief Commercial Officer | Advisor | Business Strategy & Scaling | Revenue Growth | Board Member
Angelike Kefalas, Mba Work Experience Details
-
Chief Commercial Officer (Cco)Muse® By Interaxon Inc. Apr 2024 - PresentToronto, Ontario, CaInteraxon (Muse Health AI) is a pioneering brain health company that is on a mission to improve neurological conditions through its industry-leading EEG neurofeedback platform, built on advanced A.I. algorithms.
-
Member Of Advisory BoardTopmd Dec 2019 - PresentSouthampton, Hampshire, GbTopMD is a genomics A.I. technology driven SaaS data science company that uses Next Generation Sequencing (NGS) outputs along with deep learning and pattern discovery steps associated with A.I. to power a Discovery Engine Platform that serves as a "molecular GPS". By using genomic sequencing and identifying biomarker targets and pathways, TopMD Precision Medicine Ltd is able to use its multi-disease cloud-based software platform to realize the precision medicine and companion diagnostics promise for oncology, autoimmune diseases, and more.TopMD's Precision Medicine B2B and B2B2C software tool can: 1) accelerate the ability to understand diseases allowing for targeted treatment of patients according to the person-specific molecular pathology, 2) increase the pace of drug discovery development of new medicines, and 3) potentially unlock mysteries of the human body thereby making clinical trials more successful by better patient targeting. -
Chief Business OfficerRenegade.Bio 2022 - 2023Renegade.bio was a COVID PCR laboratory that shifted to a CLIA specialty diagnostic testing and genomic sequencing laboratory. I worked closely with the CEO, leadership team, and Board to drive all aspects of the commercial business. Using my extensive experience launching DTC products in the clinical diagnostics and biotech industry, I was able to set business strategy and attract strategic partners in a short period of time. • Some of my responsibilities included directing and leading a team of 15 people in Sales, Marketing, Customer Service as well as setting commercial strategy, corporate development, product pipeline expansion, and payer reimbursement strategies • Negotiated and closed a 6,000+ clinic and hospital channel partner agreement (within 6 months of being hired) • Led corporate and brand awareness campaigns which led to several TV news and media interviews -
Consultant & Business AdvisorTrellus Health Nov 2021 - Apr 2022White Plains, New York, UsTrellus Health is a digital health / telehealth solution combining validated resilience-driven mental health tools along with a coordinated clinical care team of healthcare professionals for better outcomes along with cost savings. I helped the Executive Team and Founders strategize and execute on business expansion ideas, marketing, and sales channel growth tactics. -
Chief Business And Commercial OfficerPinpoint Science Inc 2018 - 2022San Francisco, Ca, UsPinpoint Science was an In Vitro Diagnostic (IVD) & bioinformatics start-up developing a point-of-care medical device (handheld reader + disposable cartridge + App). Pinpoint’s technology used molecular electronic nanosensor chips to immediately (within seconds) inform clinical decision-making in infectious diseases, oncology and general health. I was employee #4 hired by academic co-Founders to insert business processes & policies, build and scale company. • I led multiple departments including: Business Development, Sales, Marketing, Market Research, Competitive Intelligence, Financial Planning & Analysis and Commercial Operations• I also created and led U.S. and Global go-to-market (GTM) commercial product launch plans• Served as the commercial perspective / 'voice of the customer' to the product teams which include engineering, software and clinical.• Developed and orchestrated short- and long-term global strategy and sales frameworks, including organizational structure, goal setting, customer growth, customer type and channel strategy• Sourced, negotiated and signed development partnership deals, sales channel deals and licensing deals with pharmaceutical companies. • Continuously explored global revenue expansion opportunities as well as provided operational business leadership for M&A and enterprise commercial partnership opportunities as well as supported CEO's fundraising efforts.• Fiscal/budget planning: Territory & account planning, GTM sales team incentive design, fiscal year execution budget, headcount planning• I served as the Business Lead in 2020 & 2021, when Pinpoint was awarded multiple $MM grants and accepted into NIH Rapid Acceleration of Diagnostics program (RADx) which helped Covid test developers quickly commercialize and scale their products. -
Board MemberPinpoint Science Inc 2017 - 2022San Francisco, Ca, Us
-
Vice President, Commercial StrategyPinpoint Science Inc Jun 2017 - Jun 2018San Francisco, Ca, UsWrote business plan Collaborated with founders to raise SEED round with Angel investors as well as apply for Federal NIH Grants. Led business development, FDA regulatory planning, strategic business planning as well as multiple product development initiatives bringing customer voice to software and hardware development teams
-
Head Of Global Product Launch, Commercial Ops, Marketing & CommunicationsMedicines360 (Partnered With Allergan) 2014 - 2017Medicines360 is a biopharmaceutical company.• Globally launched Liletta® /Avibela® an FDA approved medical product with co-promote partner Allergan, in a highly competitive $5B market of Women’s Reproductive Health. My GTM and Launch awareness tactics created transformational change in the category, growing it exponentially. • Built, scaled and oversaw sales team and implemented processes including Playbooks, Sales Methodologies, and Sales Stage Management Guides. Also implemented Salesforce.com as the companies CRM reporting tool• Developed a commercial enablement strategy with a focus on increasing rep knowledge, facilitating the deal cycle, and improved rep onboarding and eLearning curriculum • In addition, I was responsible for developing product positioning, branding and implementing a cohesive Marketing, Sales and Go to Market (GTM) Launch plan—with P&L responsibility for Liletta® including the execution of 1st, 2nd and 3rd-year brand and tactical promotional plans. (Efforts resulted in an increase of product awareness from 6% to 67% (in less than 9 months), and beating sales projections YOY).• Hired, inspired and directed an internal team as well as multiple external consultants and Agencies on the creation of 500+ original promotional content materials—with a $MM budget.• PR efforts resulted in >26 unique media interviews, 53 interest articles (in less than a year’s time) including drawing 1+ Million visitors to website in a day.
-
Vice President MarketingAmplify Health (Merged With Renaissance Health In 2014) 2014 - 2014Amplify Health was a SaaS health data analytics (EMR / EHR integration) startup. I was hired by the CEO Founder to clearly articulate the company's brand and positioning, communicating complex ideas and workflows into an understandable narrative and sales pitch. Conducted customer research to identify product value and created a new website, marketing materials, slide decks, case studies, white papers, etc. for B2B (Hospitals, Payers, Employers) customers—translating technical information into relevant messages that resonated with customers, partners and future investors. Amplify Health (merged with Renaissance Health in 2014) was an enterprise software application and SaaS health analytics startup that sold its EHR software to ACOs, Large Physician Groups, Hospitals, Employers and Healthcare Insurance companies. Started as a consultant and was brought on full-time as the 7th employee.
-
Executive Director CommercialTethys Bioscience (Acquired By Hdl) 2011 - 2014Tethys Bioscience, Inc. was a cardiometabolic In Vitro Diagnostic (IVD) company (molecular assay + algorithm) that commercialized PreDx. • I was hired in 2011 by new CEO, to turn-around a failed product launch and drive product awareness, revenue growth and market position worldwide, while optimizing commercial operations. • Created new physician and patient customer acquisition and retention initiatives that drove up awareness and sales—and in 6 months doubled sales.• Implemented cutting-edge marketing tactics, promotional partnerships (Biggest Loser TV show, LoseIt App, WebMD) and new product offerings that led to increased customer engagement and exponential sales funnel expansion—with sales increasing by 830% in 2 years.• Proactively identified commercial opportunities and obstacles and developed innovative solutions • Led and managed Commercial Operations, Market Research, Competitive Intelligence, Marketing, and Sales Analytics (implementing Salesforce.com as a new CRM for Sales tracking & reporting)• Provided leadership for M&A and enterprise commercial partnership opportunities.• Promoted from Director, Strategic Marketing
-
Oncology Project Leader / ConsultantUcsf Medical Center 2008 - 2012San Francisco, Ca, UsUCSF CANCER CENTER (Mt. Zion)Part of the founding team of the Cancer UC Collaborative project with world renowned cancer surgeon who keeps challenging the status quo with a focus of “no two cancer patients should be treated the same” (see media link). • I co-led 3 teams— the Pathology, BioBank/BioRepository and Radiology teams—consisting of top cancer pathologists, surgeons, oncologists, and radiologists from all 5-UC Cancer Hospitals (UCLA, UCSF, UC Davis, UCSD, UC Irvine) to unify diagnosis terminology and data systems in order to search and extract records and samples from all 5 bio banks thereby enhancing research discovery and clinical trial participation. • The Cancer Collaborative project raised >$25M to successfully connect for the first time all 5 U.C. Cancer Centers, on a Big Data scale. • Built Knowledge Networks by sharing data, knowledge, and ideas which helped both scientists and physicians build on knowledge gained by others to advance the field of cancer medicine. • The project also funded the infrastructure needed to make it easier to share data and knowledge.• One of the primary goals of the project was to break down research silos, fostering collaboration, reshaping research culture, and providing physicians and researchers access to top-notch resources—including access to cutting-edge lab equipment, essential resources, and comprehensive training. -
Director, Product MarketingNeurogesx (Acquired By Acorda Therapeutics) 2008 - 2011Launched Qutenza®, an FDA approved therapeutic treatment of pain associated with Post-Herpetic Neuralgia (PHN) sold through Specialty Pharmacy channels.• Executed a variety of marketing tactics that were Physician, Patient or Payer directed as well as supported the sales growth at Specialty clinics and Hospitals. • Multi-Channel Marketing efforts included: HCP and Patient materials, Digital Marketing (search optimization, blog Ads, YouTube Videos, FaceBook Ads, Google Ad word buys, Email campaigns), Patient Advocacy Campaigns, Speaker Bureau, webinars, Conference sponsorship/exhibiting, Sales lead generation, Advisory Boards, marketing communications and public relations.• Ran the “Promotional and Advertising Review Committee” (PARC) that reviewed marketing materials and communications from a regulatory and compliance perspective (FDA, PDMA, and PhRMA).NeurogesX (acquired by Acorda Therapeutics) was a publicly-traded commercial-stage biotechnology company.
-
Director Global Strategic Marketing, Market Research And AnalyticsAbbott 2007 - 2008Abbott Park, Illinois, UsHired by and reported to the Chief Commercial Officer (CCO) to be a change agent and ignite sales—charged with turning around a failing product brand that was losing market share quarter after quarter. Led several departments including global Strategic Planning, Market Research and Business Analytics functions for the FreeStyle® brand. Successfully relaunched Freestyle glucose meter achieving >$2 Billion ARR in global sales in a short period of time.• Led the FreeStyle® brand team through the process of rebranding, deriving consumer insights from segmentation research and patient journey market research. *Rebranding efforts led to immediate increases in sales and regaining a competitive advantage that resulted in market share gains and YoY sales growth for several consecutive years. Today Freestyle is the #1 glucose meter and it has not gone through a rebranding again. • Led the “Strategic Market Planning Process” which included drafting: commercial plan tactics, competitive sales playbooks, SWOT analyses, forecasts, and life-cycle plans (LCPs). • Worked closely with Commercial Sales Force Area Heads (US, EU, Latin America, Asia Pac) and R&D teams to support launched to early-phase products.• Trained in public speaking and spoke at several sales meetings that consisted of 2,000 sales reps.• Performed multiple in-licensing evaluations with a focus on M&A and strategic partnerships.• Directed a global department of 20 with 6 direct reports based in Germany and the U.S. and managed a $MM budget.Leadership Awards & Recognition: • One of a select-group of high-potential Director-level employees asked to participate in the global commercial Management Development Program.• Also, appointed to Abbott’s corporate Political Action Committee (PAC) council which, is part of the pharmaceutical super PAC that lobbies for and against healthcare legislation and policy. -
Associate Director, Commercial Strategy & AnalysisNuvelo (Acquired By Arca Biopharma, Inc.) 2005 - 2007NUVELO was a publicly-traded biotech developing Cardiovascular and Cancer products. • Led Market Research and customer insight work for newly created Commercial Department. • Also, an integral part of developing a cohesive global go-to-market Marketing and Sales plan for ALFIMEPRASE®, a 510 (k) medical device drug product that was partnered to Bayer Pharmaceuticals for ex-US commercialization. A few of the items I worked on were: o Creating a global Positioning & Brand plan (with partner Bayer who had ex-US rights), o Developing a Message platform, o Creating a Pricing strategy that supported 5 indications and o Developing a global launch / GTM tactical plan.• In addition, I was the commercial Team Member Lead to several pipeline products for the treatment of cancer. Activities included: refining TPPs, identifying the value proposition, competitive analysis, product forecasting, product labeling, thought leader development, pharmaco-economic evaluations and life-cycle planning.
-
Team Leader, New Product Planning & Business DevelopmentNektar Therapeutics 2003 - 2005San Francisco, California, UsNektar is a publicly traded biotechnology company with 1,000-2,000 employees. • Project Team Leader for 5 new products. Created clear goals, supported efforts, and ensured project alignment across senior management & departments. • Wrote mini-business plans for each therapeutic product under consideration for pipeline inclusion and resource funding. Mini-business plans incorporated cross-functional project team ideas to mitigate development risk and optimize market returns as well as market research and competitive landscape analysis (plans included: market assessment, R&D plan, regulatory path, clinical trial plans, manufacturing, IP landscape (FTO analysis), financials and budgets, as well as a go-to-market strategy). Therapeutic categories included: Asthma, Cancer treatments using Pegylated Irinotecan, Interferons for Solid Cancers, Cystic Fibrosis (CF), Diabetes, Hemophilia (Factor VIII), Lung Cancer, Migraine, Non-Hodgkin’s Lymphoma (NHL), Osteoporosis, PTH, Parkinson’s Disease, Panic Attack Disorder, to name a few.• Part of a product prioritization effort (after an M&A), I analyzed 50+ therapeutic product opportunities. Presented go/no-go assessments to senior management for decisions. -
Senior Business Development ConsultantXoma 2001 - 2003Emeryville, California, UsXOMA was a publicly-traded biotechnology company focused on developing therapeutic humanized monoclonal antibodies and proteins.• Reported to CFO • Led negotiations on more than six technology deals; including a pre-clinical collaboration with Millennium Pharmaceuticals in 2002 that had a $37 Million upfront payment.• Conducted Market Research and Competitive Intelligence activities that assessed market need, financial potential, and barriers to entry (physician/patient attitudes, product usability, reimbursement). • Provided actionable recommendations to product teams and senior management including: commercial assessments, forecasts and life-cycle plans. • Commercial launch lead for Raptiva®, an anti-CD11a humanized monoclonal antibody approved for Psoriasis, with partner GenentechProduct Pipeline Therapeutic markets included: Oncology (CLL, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer), Ophthalmic disorders and Infections, Cardiovascular disease, Rheumatoid Arthritis, and Organ Transplant Rejection, among others. -
AnalystDecision Resources Group 1999 - 2001Burlington, Massachusetts, UsDecision Resources, Inc. provides syndicated market research, advisory services, and consulting for the pharmaceutical, biotechnology, and healthcare technology companies (200-500 employees). Led research teams and projects from cradle to grave. Conceived ideas for research and report topics, built research plans, wrote survey instruments, weighted and analyzed qualitative and quantitative data, and authored reports for a senior executive audience that focused on the strategic business implications of my findings, which helped biotech and pharma companies allocate R&D resources, change marketing strategies and anticipate revenue opportunities.Authored reports on the following disease categories: Atherosclerosis Disease, Asthma Disease, Alzheimer’s Disease, Multiple Sclerosis, Osteoporosis, Prostate Cancer, and Non-Small Cell Lung Cancer -
Gic Health Policy Analyst, Plan Program Manager, & Interim Budget DirectorCommonwealth Of Massachusetts 1997 - 1999Boston, Ma, Us• Wrote policy responses to proposed legislation and lobbied for and/or against certain health policy measures at the State and Federal level. • Ran analytical reports using the State’s all-payer claims database to drill into patient claims and aggregate procedure-level cost data in order to quantify costs and inform policy decisions for healthcare bills and proposed legislation. • Program Manager to 2 of the largest Health Insurance Providers, the State's PPO plan (Tufts Health plan) and the State's PBM (Pharmacy Benefits Manager (Merck Medco). • In 1998 I was assigned the responsibilities of interim Budget Director, leading the daily management and reporting of the Group Health Insurance Commission’s (GIC) $600M budget to the Executive Director, GIC Board, and Governor's office through 2 budget cycles (FY1998 & FY1999).
Angelike Kefalas, Mba Skills
Biotechnology
Pharmaceutical Industry
Clinical Development
Strategy
Lifesciences
Infectious Diseases
Clinical Trials
Immunology
Commercialization
Start Ups
Cross Functional Team Leadership
Oncology
Medical Devices
Biopharmaceuticals
Marketing Strategy
Business Development
Project Management
Life Sciences
Leadership
Customer Acquisition
Social Media Marketing
Product Launch
Customer Insight
Marketing
Product Development
Strategic Planning
Fda
Healthcare
Pharmaceutics
Product Management
Digital Marketing
Digital Strategy
Product Marketing
Business Strategy
Market Research
Market Planning
Drug Development
Competitive Intelligence
Analytics
Market Access
Segmentation
Customer Relationship Management
Customer Engagement
Customer Service
Teamwork
Team Leadership
Management
Medical Diagnostics
Target Marketing
Targeted Advertising
Angelike Kefalas, Mba Education Details
-
Columbia Business SchoolGeneral -
University Of California, Berkeley, Haas School Of BusinessMaster Of Business Administration - Mba
-
London Business SchoolGlobal Economics & Marketing Classes With Joseph E. Stiglitz And Bruce Greenwald
-
Brandeis UniversityCell/Cellular And Molecular Biology
Frequently Asked Questions about Angelike Kefalas, Mba
What company does Angelike Kefalas, Mba work for?
Angelike Kefalas, Mba works for Muse® By Interaxon Inc.
What is Angelike Kefalas, Mba's role at the current company?
Angelike Kefalas, Mba's current role is Chief Business Officer | Chief Commercial Officer | Advisor | Business Strategy & Scaling | Revenue Growth | Board Member.
What is Angelike Kefalas, Mba's email address?
Angelike Kefalas, Mba's email address is an****@****ail.com
What is Angelike Kefalas, Mba's direct phone number?
Angelike Kefalas, Mba's direct phone number is +151042*****
What schools did Angelike Kefalas, Mba attend?
Angelike Kefalas, Mba attended Columbia Business School, University Of California, Berkeley, Haas School Of Business, London Business School, Brandeis University.
What skills is Angelike Kefalas, Mba known for?
Angelike Kefalas, Mba has skills like Biotechnology, Pharmaceutical Industry, Clinical Development, Strategy, Lifesciences, Infectious Diseases, Clinical Trials, Immunology, Commercialization, Start Ups, Cross Functional Team Leadership, Oncology.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial